CYFUSE BIOMEDICAL
Cyfuse Biomedical develops tissue fabrication systems and cell-based products in Japan and internationally. The company offers 3D BioFabrication systems and related consumables; develops and licenses 3D tissue products for therapeutic and drug development use; and engages in contract manufacturing of 3D tissue products for research purposes. Its products applications include blood vessel grafts for blood access of hemodialysis patients or coronary artery bypass grafts; cardiac grafts for drug t... oxicology screening or supplemental therapy of myocardial infarction; cartilage grafts for plastic surgery or reconstruction; and hepatocyte grafts for drug metabolism screening or in-vivo production of clotting factors in the treatment of hemophilia. Cyfuse Biomedical was founded in 2010 and is based in Tokyo, Japan.
CYFUSE BIOMEDICAL
Social Links:
Industry:
Biotechnology Health Care Medical Device
Founded:
2010-08-11
Address:
Tokyo, Tokyo, Japan
Country:
Japan
Website Url:
http://www.cyfusebio.com
Total Employee:
1+
Status:
Active
Total Funding:
29.78 M USD
Technology used in webpage:
LetsEncrypt Euro Pound Sterling Japanese Yen GMO Internet
Similar Organizations
Cnoga Medical
Cnoga Medical empowers people with easy-to-use, non-invasive medical devices.
CuResponse
Curesponse is a medical company developing a three-dimensional tissue culture system for modeling cancer growth and drug response.
Sesen Bio, Inc.
Sesen Bio, Inc. is focused on developing innovative protein-based therapeutics to improve human health and treat diseases.
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
Current Advisors List
Current Employees Featured
Founder
Investors List
Fujimori Kogyo
Fujimori Kogyo investment in Venture Round - Cyfuse Biomedical
Iwatani Corporation
Iwatani Corporation investment in Venture Round - Cyfuse Biomedical
Mitsubishi UFJ Capital
Mitsubishi UFJ Capital investment in Venture Round - Cyfuse Biomedical
Taiyo Holdings Co.
Taiyo Holdings Co. investment in Corporate Round - Cyfuse Biomedical
Mitsubishi UFJ Capital
Mitsubishi UFJ Capital investment in Venture Round - Cyfuse Biomedical
Shinsei Bank
Shinsei Bank investment in Venture Round - Cyfuse Biomedical
Nippon Venture Capital
Nippon Venture Capital investment in Venture Round - Cyfuse Biomedical
QB Capital
QB Capital investment in Venture Round - Cyfuse Biomedical
Nissay Capital
Nissay Capital investment in Venture Round - Cyfuse Biomedical
Fujifilm
Fujifilm investment in Venture Round - Cyfuse Biomedical
Official Site Inspections
http://www.cyfusebio.com Semrush global rank: 4.11 M Semrush visits lastest month: 2.95 K
- Host name: sv16261.xserver.jp
- IP address: 85.131.207.2
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "Cyfuse Biomedical"
Company ｜ Cyfuse Biomedical K.K.
Company name: Cyfuse Biomedical K.K. (Japanese corporation) CEO: Shizuka Akieda: Founded: August 11, 2010: Address: South Tower-1F. Sumitomo Fudosan Tokyo Mita, 3-5 ...See details»
Cyfuse Biomedical K.K.
CYFUSE FUKUOKA. Tenjin Business Center 9F, 1-10-20, Tenjin, Chuo-ku, Fukuoka City, Fukuoka 810-0001, JAPANSee details»
About Cyfuse - Cyfuse Biomedical K.K.
New Treatment Options for Patients. Against the backdrop of the increasingly expanding practical application and industrialization of regenerative medicine and cellular therapy, Cyfuse has been hard at work primarily on the development …See details»
Cyfuse Biomedical K.K. | LinkedIn
Cyfuse Biomedical K.K. | 955 followers on LinkedIn. Cyfuse contribute to significant advances in medical treatments and drug discovery through its revolutionary 3D tissue-engineering technology.See details»
The Forum for Innovative Regenerative Medicine (FIRM) Ver.1.0 …
Organization. Name of Organization * Cyfuse Biomedical K.K. Address, City, States, Zip, Country * West Wing-1F, Sumitomo Fudosan Mita Twin Bldg. 3-5-27, Mita, Minato-ku, Tokyo. URL. …See details»
会社情報 - 株式会社サイフューズ
会社名: 株式会社サイフューズ: 代表者: 代表取締役 秋枝 静香: 設立日: 2010年8月11日: 所在地 〒108-6301 東京都港区三田3-5-27 住友不動産東京三田サウスタワー1fSee details»
株式会社サイフューズ
サイフューズ東京 〒108-6301 東京都港区三田3-5-27 住友不動産東京三田サウスタワー1f tel ： 03-6435-1885 fax ： 03-6435-1883See details»
Cyfuse Biomedical - Crunchbase Company Profile & Funding
Cyfuse Biomedical develops tissue fabrication systems and cell-based products in Japan and internationally. The company offers 3D BioFabrication systems and related consumables; …See details»
Cyfuse Biomedical K.K.｜J-Startup
Our company name "Cyfuse", which combines "Cyto" meaning "cell" and "Fusion", symbolizes regeneration using cells and our hope to create new value that is useful to people and society …See details»
Cyfuse Biomedical K.K. Company Description - Stock Analysis
Mar 25, 2025 Cyfuse Biomedical K.K. engages in the development, manufacture, and sale of regenerative medicine products in Japan. It develops cellular products in the field of …See details»
Introduction ｜ Cyfuse Biomedical K.K.
“Creating a New Society and Contributing to Global Therapies Using the Power of Cells and Bio 3D Printing” Since its establishment in 2010, Cyfuse has been in business with the mission of making social contributions in the medical field, …See details»
サイフューズの再生医療 ｜ 株式会社サイフューズ
株式会社サイフューズのオフィシャルサイトです。サイフューズは「細胞」から、新しい医療という「希望」を創出する ...See details»
PHC and Cyfuse Develop Innovative Production Technology for …
March 19, 2025 (Tokyo, Japan) -- PHC Corporation (Headquarters: Chiyoda-ku, Tokyo; President: Nobuaki Nakamura; hereafter referred to as "PHC"), a subsidiary of PHC Holdings Corporation …See details»
サイフューズとは ｜ 株式会社サイフューズ
新しい治療の選択肢を 患者さまへ. サイフューズは、再生医療・細胞医療の実用化・産業化が広がりをみせる環境下において、当社独自の基盤技術を搭載した最新鋭のデバイスによって革 …See details»
Management Team - Cyfuse Biomedical K.K.
Cyfuse contributes to significant advances in medical treatments through its revolutionary 3D tissue-engineering technology.See details»
PHC and Cyfuse Develop Innovative Production Technology for …
March 19, 2025 PHC Corporation. March 19, 2025 (Tokyo, Japan) -- PHC Corporation (Headquarters: Chiyoda-ku, Tokyo; President: Nobuaki Nakamura; hereafter referred to as …See details»
Cyfuse Biomedical (Japan) Funding: $29.8M - Medical Startups
Mar 27, 2025 We contribute to significant advances in medical treatments through our revolutionary 3D tissue-engineering technology. We successfully developed the BIO 3D …See details»
PHC and Cyfuse Develop Innovative Production Technology for …
Mar 19, 2025 TOKYO, JP – PHC Corporation (Headquarters: Chiyoda-ku, Tokyo; President: Nobuaki Nakamura; hereafter referred to as “PHC”), a subsidiary of PHC Holdings Corporation …See details»
テレビ東京「WBS（ワールドビジネスサテライト）」にて、サイ …
Mar 11, 2025 株式会社サイフューズのオフィシャルサイトです。サイフューズは「細胞」から、新しい医療という「希望」を創出する ...See details»
2024年12月期 決算説明資料（概要版） - cyfusebio.com
2024年12月期の達成と今後の成長戦略 05 経営方針 及び 成長戦略 2024年12月期（成長期）における達成事項-開発面（製品上市の蓋然性向上）、事業面（将来の収益性向上）を着実に達 …See details»